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Women can be considered hemodynamically younger than
men of the same age, based on epidemiological studies estab-
lishing that the incidence of vascular diseases in women is
relatively lower compared to that in aged-matched men.
However, after menopause, these numbers increase to values
that are close to those found in men. Vascular ageing is asso-
ciated with structural and functional changes of the vascular
wall, including endothelial dysfunction, arterial stiﬀening,
and remodelling, as well as impaired angiogenesis, which
become major risk factors in the development of cardiovas-
cular disease. Data from clinical and basic research have
established that vascular ageing does not follow the same
timeline in women as it does in men. Although vascular dys-
function and cardiovascular risk factors are comparable in
elderly men and women, the rate of change is lower in
women during their fertile years. This age- and sex-related
diﬀerence in the progression of vascular dysfunction is not
completely understood, although experimental and observa-
tional clinical studies have attributed most of the vascular
protection in women to estrogen and its modulatory action
in the vascular system via interaction with its receptors
ERα, ERβ, and G protein-coupled estrogen receptor (GPER).
Nevertheless, there is much controversy surrounding the
clinical use of estrogen as a therapeutic strategy in primary
and secondary prevention of vascular disease in women.
Contrary to the observational studies suggesting the value
of estrogen to vascular health in women, clinical trials such
as theWomen’s Health Initiative (WHI) reported an increase
in cardiovascular events in women treated with estrogen
replacement therapy compared with those treated with
placebo. A main reason for the discrepancy among studies
is that women enrolled in the clinical trials were on average
10 years older than those included in the observational stud-
ies. When analyses are done by the age group, it is revealed
that estrogen therapy produces more favourable results in
younger women (closer to onset of menopause) than in the
late average onset enrolled in most trials. These analyses led
scientists to conceive the so-called “timing hypothesis,”
which relies on the concept that estrogen has beneﬁcial
eﬀects only if taken before, or close to, the onset of meno-
pause, at which time the detrimental eﬀects of ageing have
not yet been established in the vasculature.
Among the mechanisms underlying the estrogen-
mediated eﬀects on vascular function are anti-inﬂammatory
and antioxidative actions, as well as epigenetic modiﬁcations,
all of which are inﬂuenced by ageing. In fact, a great burden
of oxidative stress is seen during ageing and menopause
which can contribute to vascular dysfunction. That way,
oxidative stress together with the inﬂammatory activation
of the vascular endothelium induces a wide range of local
and systemic responses, such as the expression of adhesion
molecules, the production of chemotactic factors, and free
radicals that could regulate the vascular eﬀects of estrogen.
Thus, the vasoprotective eﬀects seen in younger women, in
the perimenopause or close to menopause onset, could
become detrimental when women get older.
This special issue presents novel and updated research
regarding the mechanisms by which estrogen modulates
metabolism and vascular homeostasis in diﬀerent stages of
women’s health including menarche, pregnancy, and
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menopause. With special focus on oxidative stress, these
mechanisms could be pivotal for the development of novel
therapeutic strategies to prevent and treat vascular disease
in women. The manuscripts within this special issue are all
equally recommended by the editors, and they contain espe-
cially interesting points worth commenting on.
Estrogens are important modulators of lipid metabolism
and contribute to the low prevalence of atherosclerotic vascu-
lar disease. However, estrogen promotes the synthesis of
triglycerides (TG) in the liver and secretes TG into the circu-
lation as very-low-density lipoprotein (VLDL) particles,
being the hypertriglyceridemia one of the ﬁve pathological
traits that characterize metabolic syndrome. In fact, an asso-
ciation exists between early menarche and an increased risk
of metabolic syndrome. To better understand this relation,
H.-S. Lee et al. identiﬁed through a GWAS-based pathway
analysis an association among type 2 diabetes mellitus,
stress-activated protein kinase (SAPK) signalling, and Jun
amino-terminal kinase (JNK) cascade pathways with TG
including the genetic interaction with age at menarche.
Type 2 diabetes is an age-associated disease in which oxi-
dative stress is involved, the prevalence is higher in men than
in women, and therefore, there are sex-associated diﬀerences.
In the original study developed by A. Díaz et al., the role of
estrogens in protecting against oxidative stress in type 2
diabetic Goto-Kakizaki male and female rats is evaluated.
Performing an in-depth study in glucose metabolism, by
positron emission tomography, metabolomics, and mito-
chondrial activity measurements, these authors provide evi-
dence for the beneﬁcial eﬀects of estrogen in ovariectomized
type 2 diabetes female rats.
Estrogen also plays a pivotal role in the control of vascu-
lar function during pregnancy. Normal gestation is associ-
ated with a mild oxidative stress, which is increased in
pregnancy complications, such as preeclampsia and intra-
uterine growth restriction. Estrogen regulates uterine artery
function via upregulation of endothelial nitric oxide synthase
(eNOS) in endothelial cells and the large-conductance Ca2+-
activated K+ (BKCa) channel in vascular smooth muscle cell.
The review presented by X.-Q. Hu et al. provides an updated
understanding of the regulation of the estrogen-NOS-NO-
KCa pathway by reactive oxygen species in uteroplacental tis-
sues and gives an overview of a link between oxidative stress
and uteroplacental dysfunction in pregnancy complications.
Female sex hormones also play a predominant role in
varicose physiopathology, especially considering the inﬂu-
ence of sex and pregnancy on varicose vein development.
The original study proposed by N. García-Honduvilla et al.
is aimed at verifying the involvement of steroid receptors
and progesterone, estrogen, and androgen receptors in vari-
cose vein development, focusing on sex diﬀerences. In both
sexes, they observed an increase in sex hormone receptors
under varicose vein conditions and highlight the importance
of the redistribution of these receptors.
Finally, estrogen also modiﬁes cardiovascular function by
modulating gene expression, either directly acting as tran-
scriptional factors or indirectly via epigenetic regulation. In
this sense, miRNAs have emerged as a new regulatory mech-
anism of both physiological and pathological processes, as
they regulate gene expression proﬁles at the posttranscrip-
tional level. Epigenetic changes in the vascular action of
estrogens in ageing are deeply reviewed in the work by D.
Pérez-Cremades et al. Emerging studies propose a role for
miRNA in the vascular eﬀects mediated by estrogens, and
in this work, the authors highlight the current knowledge
on the role of estrogen-sensitive miRNAs and their inﬂuence
in regulating vascular ageing. This review sheds light on the
potential of translating miRNA research into the clinic, using
miRNAs as potential tools for the diagnoses and/or progno-
ses of cardiovascular disease, as aﬀordable and noninvasive
biomarkers, and as a therapeutic tool for regulating (silencing
or increasing) miRNA levels.
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